Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-05 @ 8:19 PM
Study NCT ID:
NCT01080027
Status:
COMPLETED
Last Update Posted:
2014-07-31
First Post:
2010-03-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR)
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EMR 701068_506
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None